REAL-WORLD EFFECTIVENESS OF VEDOLIZUMAB AND ANTI-TUMOUR NECROSIS FACTOR ALPHA TREATMENT OVER 6 MONTHS IN CROHN'S DISEASE PATIENTS: A GERMAN RETROSPECTIVE CHART REVIEW

Ulf Helwig  1     Michael Mross  2     Stefan Schubert  3     Heinz Hartmann  4     Alina Brandes  5     Christian Kempf  6     Jana Knop  7     Sarah Campbell-Hill     Robert Ehehalt    
1 Verein für Wissenschaft und Fortbildung,Oldenburg,Germany
2 Specialist Gastroenterology Practice,Berlin,Germany
3 Praxis,Berlin,Germany
4 Gastroenterology Private Practice,Goettingen,Germany
5 Takeda Pharma Vertrieb GmbH & Co. KG,Berlin,Germany
6 Takeda Pharmaceuticals International - Zurich Branch,Zurich,Switzerland
7 Takeda Pharma Ve

Conference
UEG Week 2018

Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing